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ABSTRACT
We report the case of a 6-year-old male who developed 
recurrent erythema nodosum (EN) at the age of 3 years. 
The patient exhibited hypertelorism, low-set ears, mi-
crognathia, moderate intellectual disability, thin long 
fingers, loose anagen hair, and prominent palmoplantar 
wrinkles. A heterozygous single nucleotide variant in the 
SHOC2 gene (c.4 A > G, p.S2G) was identified. Patients 
with a SHOC2 mutation exhibit a unique combination 
of ectodermal abnormalities including darkly pigmented 
skin and loose anagen hair. This report is the first to 
describe EN in a patient with SHOC2 mutation, and to 
examine the patient’s hair using scanning electron mi-
croscopy. We hypothesize that the RAS/MAPK pathway 
is associated with the pathogenesis of cutaneous lesions 
in patients with SHOC2 mutations via autoinflammation 
and disturbance of epithelial stem cells.
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The SHOC2 gene on chromosome 10q25.2 encodes a 
product containing leucine-rich repeats and acts as a 
positive modulator of the RAS/MAPK pathway. Patients 
with a gain-of-function missense mutation c.4A > G 
(p.S2G) in SHOC2 exhibit Noonan syndrome-like 
symptoms with loose anagen hair.1
 Previous studies have reported patients with a 
SHOC2 mutation manifesting multiple phenotypes 
including intellectual disability and dysmorphic facial 
features. Additionally, these patients display a unique 
combination of ectodermal abnormalities including 
darkly pigmented skin and loose anagen hair.1, 2 The 
present patient exhibited recurrent erythema nodosum 
(EN), which has not been reported previously in patients 
with a SHOC2 mutation. In this study, we describe 
recurrent EN using scanning electron microscopy (SEM) 
to examine the hair in a patient with a SHOC2 mutation. 
These findings may be useful in understanding the cuta-
neous symptoms of this syndrome.
PATIENT REPORT
A 6-year-old male was born to nonconsanguineous 
parents at 38 weeks with a birth weight of 3,190 g (stan-
dard deviation [SD], +0.4), height of 47 cm (SD, −0.9), 
and head circumference of 33.5 cm (SD, ±0). He was 
referred to our hospital at the age of 1 year 1 month due 
to exhibited global developmental delay. He was capable 
of walking at 2 years and 1 month of age and uttered the 
first meaningful word at 3 years and 5 months of age.
 Physical examination at 1 year and 3 months of age 
revealed generalized hypotonia and facial dysmorphisms 
including hypertelorism, low-set ears, and micrognathia. 
He had thin long fingers and prominent palmoplantar 
wrinkles. Bone X-ray revealed tapered distal phalanges 
of the fingers (Fig. 1A).
 He experienced the first emergence of multiple and 
painful erythema (2–3 cm in diameter) on the lower leg 
at 3 years and 9 months of age. The erythema recurred 
every 2–3 months without other symptoms or infectious 
episodes and spontaneously disappeared within 2 days 
(Fig. 1B). Skin biopsy revealed typical findings of 
septal panniculitis with lymphocytic, neutrophilic, and 
eosinophilic infiltration in the absence of vasculitis (Fig. 
1C). The levels of autoantibodies, including antinuclear 
antibody and Sjögren syndrome-related antibodies, were 
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Fig. 1. A: Skeletal X-ray at 1 year of age showing tapered distal phalanges (arrows). B: Erythema appearing on the anterior surface of the 
lower leg at 3 years of age (arrow heads). C: Histopathology of an erythema showing perivascular and septal infl ammatory infi ltration in 
the subcutaneous adipose tissue (Hematoxylin–Eosin staining, bar = 100 μm).
Fig. 2. A: Sparse scalp hair at 5 years of age. The surface of the scalp is partially exposed because of hair loss. B–E: Scanning electron 
microscopy images of the patient’s hair at 5 years of age. (B) Trichorrhexis represented as a focal longitudinal vulnerable lesion of the hair 
shaft. (C) The hair shaft showing a sagged or peeled surface. (D) Trichoptilosis represented as a longitudinal splitting and cracking lesion 





not elevated in the serum.
 A physical examination at 6 years and 4 months of 
age revealed generalized hypotonia; however, muscle 
power and deep tendon refl exes were normal. His weight 
was 14.7 kg (SD: −1.2), height was 100.8 cm (SD: −1.7), 
and head circumference was 50.8 cm (SD: −0.1). At 4 
years, the patient’s intellectual quotient was determined 
to be 52 according to the Tanaka–Binet scale of intelli-
gence.
 Easily pluckable, sparse hair had been prominent 
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since infancy (Fig. 2A). SEM revealed rough-surfaced 
hair shafts (Figs. 2B and C), longitudinal splitting of 
distal hair shafts (Fig. 2D), and distorted hair bulbs (Fig. 
2E).
 Next-generation sequencing using an Illumina 
TruSight One Sequencing Panel on an Illumina MiSeq 
platform (Illumina, San Diego, CA) was performed, 
and a heterozygous single nucleotide variant in SHOC2 
(c.4 A > G, p.S2G) was found, which was validated by 
Sanger sequencing. The parents of the patient did not 
consent to a genetic analysis of their SHOC2 genes. 
However, neither parent displayed phenotypic features 
of SHOC2. Informed consent for his genetic analysis 
was obtained from his parents following the Helsinki 
Declaration. This study was approved by the ethics 
committee at the Tottori University (dated September 
22, 2014, approval number G152).
DISCUSSION
The histopathological findings of the biopsy using 
a specimen from the leg were compatible with EN.3 
Erythema has been identified in patients diagnosed with 
RASopathies including SHOC2 mutations.1 However, 
the recurrent or single event was not specified, and the 
term “erythema nodosum” was not used. Generally, 
EN occurs as an isolated condition or in association 
with drug administration, infection, and the presence 
of connective tissue diseases.3 Notably, systemic lupus 
erythematosus has been established as a complication in 
patients with PTPN11, KRAS, and SHOC2 mutations.4 
Remarkably, activation of the H-Ras protein in the RAS/
MAPK pathway is reported to result in the pronounced 
accumulation of immune cells in mouse epidermis.5 The 
causative factors for the differential manifestation of 
either erythema or EN among patients with SHOC2 mu-
tations is still unknown, but genetically driven cutaneous 
autoinflammation may be linked to the dysregulation of 
the RAS/MAPK pathway. 
 Hair abnormality is a common feature in RASopathies, 
and loose anagen hair is a distinctive feature of patients 
with a SHOC2 mutation. Two previous reports described 
the hair characteristics of patients with this mutation us-
ing light microscopy.1,6 Similar to the findings observed 
using SEM in our patient, deformity of the hair shafts 
was described as trichorrhexis nodosa and trichoptilo-
sis, and the hair bulbs were distorted and misshapen. 
Whereas, loose anagen hair (LAH) is also shown in 
cases without SHOC2 mutation.7 Similar to our findings, 
previously report of SEM in LAH reveals distorted 
hair bulbs and cuticle scales.8 We observed the first to 
confirm these hair abnormality using SEM in a patient 
with SHOC2 mutation. KRAS-knockout mice have 
been reported to show defective hair cycling.9 The exact 
pathogenesis of loose anagen hair in patients with a 
SHOC2 mutation remains unknown; however, the RAS/
MAPK pathway, which is required for the development 
and regeneration of hair follicles, may be involved in this 
process.10 The mutation in the SHOC2 gene is believed 
to affect the proliferation, survival, or differentiation of 
epithelial stem cell-derived cells residing in hair folli-
cles.11
 We described EN in a patient with SHOC2 mutation 
and observation of the abnormal hair using SEM. Other 
RAS/MAPK pathway related disease; tuberous sclerosis 
complex (TSC) is a genetic disorder caused by mutation 
in either of the two genes TSC1 or TSC2. Recently, 
mTOR inhibitor everolimus is approved by the Food and 
Drug Administration for TSC associated partial onset 
seizure. Cortical tuber in TSC patients is important etiol-
ogy for epileptogenesis, and an increase of inflammatory 
cells in cortical tubers has been previously described.12 
Certain etiology of skin lesions and hair abnormalities 
in patients with SHOC2 mutation are still unknown, but 
genetically pathologies including inflammation may be 
linked to the symptoms. Further research are needed for 
development of treatment for these symptoms in patients 
with SHOC2 mutation.
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